Lupin gets US FDA approval for Varenicline Tablets
They are indicated for use as an aid to smoking cessation treatment
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Vibcare Healthcare opens pharma manufacturing facility in Panchkula, Haryana
Built with an investment of Rs 40 crores, the facility spans over five acres
Akums’ acquires new formulation facility in Baddi
It is slated to become operational in the year 2024
Non-stimulants face uphill battle to penetrate ADHD market despite lower abuse potential: GlobalData
A better alternative strategy to penetrate the saturated ADHD market would be to target key unmet needs in ADHD treatment such as…
AbbVie’s $10.1 bn Immunogen deal fortifies oncology portfolio, signals big pharma’s ADC…
Earlier this year, Pfizer acquired ADC giant Seagen for $43 billion in one of the largest M&A deals in industry history
Syngene concludes acquisition of biologics facility from Stelis Biopharma
The acquisition of the ‘Unit 3’ biologics manufacturing facility was concluded at a revised gross value of Rs 617 crores adjusted…
Lupin launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP in the US
Turqoz Tablets USP 0.3 mg/0.03 mg is a contraceptive drug indicated to prevent pregnancy
We are committed to delivering excellence across the pharma supply chain
Rajesh Vedak, MD, Körber India speaks about his company's innovative solutions, strategies to maintain its technological…
Zydus gets US FDA final approval for Ivabradine Tablets, 5 mg and 7.5 mg
Ivabradine is indicated to reduce the risk of hospitalisation for worsening heart failure in adult patients with stable,…
Pharma contract manufacturing sees historic surge amidst inflation and investment challenges:…
The total commercial dose contract manufacturing organisation (CMO) contract revenue year-on-year (YoY) soared by an impressive…
Enzene Biosciences launches Ranibizumab to treat neovascular AMD
Ranibizumab biosimilar is the company’s seventh biosimilar
Investment in novel therapies key priority to tackle AMR: GlobalData
As per GlobalData Pharmaceutical Intelligence Center’s pipeline drugs database, there are around 929 antibiotics and 182…
Sanjivani Paranteral, Hindustan Antibiotics partner to manufacture IV formulations and IV Sets
The partnership will see the establishment of a manufacturing facility within the premises of Hindustan Antibiotics at Pimpri…
Experts believe gene therapies will disrupt Gaucher disease drug market: GlobalData
Gaucher disease, a rare inherited metabolic disorder caused by defects in the GBA1 gene, results in harmful glucocerebroside…
Strides gets USFDA approval for generic Suprep Bowel Prep Kit
The product belongs to a group of medicines prescribed to those who are required to undergo a colon cleanse prior to a colonoscopy
Lupin launches FDC drug Vilfuro-G for COPD management in India
The launch follows the approval granted by the Drug Controller General of India for the dry powder inhaler (DPI) product
Evive, Acrotech get FDA nod for Ryzneuta (Efbemalenograstim alfa Injection) for chemo-induced…
Neutropenia is characterised by persistently low levels of neutrophils due to the use of chemotherapy and other types of…
Lupin gets US FDA approval for Dapagliflozin tablets and Pitavastatin tablets
Both the products will be manufactured at Lupin’s Pithampur facility in India
Strides gets USFDA approval for Levetiracetam Oral Solution
It is used in the treatment of seizures
Sugemalimab approval in China makes it only second drug approved globally for ENKTL: GlobalData
GlobalData forecasts sugemalimab to generate sales of $31 million (patient-based forecast) by 2030 for T-cell lymphomas in China